000 01113 a2200289 4500
005 20250518052452.0
264 0 _c20200921
008 202009s 0 0 eng d
022 _a1522-9653
024 7 _a10.1016/j.joca.2019.07.013
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWalsh, D A
245 0 0 _aA tale of two TrkA inhibitor trials: same target, divergent results.
_h[electronic resource]
260 _bOsteoarthritis and cartilage
_c11 2019
300 _a1575-1577 p.
_bdigital
500 _aPublication Type: Editorial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAnalgesics
_xtherapeutic use
650 0 4 _aAnimals
650 0 4 _aAntibodies, Monoclonal, Humanized
_xtherapeutic use
650 0 4 _aArthralgia
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aOsteoarthritis
_xcomplications
650 0 4 _aReceptor, trkA
_xantagonists & inhibitors
700 1 _aNeogi, T
773 0 _tOsteoarthritis and cartilage
_gvol. 27
_gno. 11
_gp. 1575-1577
856 4 0 _uhttps://doi.org/10.1016/j.joca.2019.07.013
_zAvailable from publisher's website
999 _c29951083
_d29951083